Treatment of painful bone metastases in hormone-refractory prostate cancer with zoledronic acid and samarium-153-ethylenediaminetetramethylphosphonic acid combined.

Translated title of the contribution: Treatment of painful bone metastases in hormone-refractory prostate cancer with zoledronic acid and samarium-153-ethylenediaminetetramethylphosphonic acid combined.

M.G.E.H. Lam, J.M.H. de Klerk, B.A. Zonnenberg

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionTreatment of painful bone metastases in hormone-refractory prostate cancer with zoledronic acid and samarium-153-ethylenediaminetetramethylphosphonic acid combined.
Original languageUndefined/Unknown
Pages (from-to)649-651
Number of pages3
JournalJournal of Palliative Medicine
Volume12
Issue number7
Publication statusPublished - 2009

Cite this